Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 7M | 14M | 13M | 17M | 17M | 16M | 13M |
| Cost of revenue | 5M | 9M | 9M | 11M | 11M | 11M | — |
| Gross profit | 2M | 5M | 4M | 5M | 5M | 5M | 4M |
| Research and development | 623,000 | 536,000 | 1M | 1M | 957,000 | 1M | — |
| Selling, general and administrative | 4M | 4M | 5M | 6M | 6M | 5M | — |
| Operating expenses | 5M | 4M | 6M | 7M | 7M | 6M | — |
| Operating income | −3M | 795,000 | −2M | −2M | −1M | −1M | −2M |
| Net income | −3M | 601,000 | −3M | −2M | −2M | −2M | −2M |
| Earnings per share | −0.15 | 0.03 | −0.15 | −0.12 | −0.11 | −0.10 | −0.13 |
| Earnings per share, diluted | −0.15 | 0.03 | −0.15 | −0.12 | −0.11 | −0.10 | −0.13 |
| Weighted average shares | 21M | 20M | 17M | 17M | 17M | 17M | — |
| Weighted average shares, diluted | 21M | 23M | 17M | 17M | 17M | 17M | — |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 2M | 1M | 505,000 | 883,000 | 559,000 | 643,000 |
| Receivables | 4M | 9M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | 889,000 | — | — | 944,000 |
| Depreciation and amortisation | — | — | 251,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 7M |
| 11M |
| 10M |
| 8M |
| 10M |
| 10M |
| Inventory | 17M | 16M | 16M | 17M | 16M | 15M | 15M | 17M |
| Current assets | 23M | 28M | 27M | 32M | 27M | 26M | 27M | 28M |
| Property, plant and equipment | 1M | 1M | 2M | 2M | 2M | 2M | 2M | 2M |
| Total assets | 26M | 30M | 30M | 35M | 31M | 29M | 31M | 32M |
| Current liabilities | 21M | 22M | 32M | 40M | 34M | 31M | 31M | 31M |
| Total liabilities | 21M | 23M | 33M | 40M | 35M | 32M | 32M | 32M |
| Equity | 5M | 8M | −3M | −5M | 4M | −3M | −1M | 194,000 |
| Shares outstanding | 21M | 21M | 17M | 17M | 17M | 17M | 17M | 17M |
| Shares issued | 21M | 21M | 17M | 17M | 17M | 17M | 17M | 17M |
| — |
| — |
| 252,000 |
| Share-based compensation | 240,000 | 285,000 | 209,000 | 206,000 | 278,000 | 347,000 |
| Capital expenditure | — | — | 163,000 | — | — | 198,000 |
| Investing cash flow | — | — | −163,000 | — | — | −198,000 |
| Financing cash flow | — | — | −472,000 | — | — | −830,000 |